Amyloid deposition is associated with impaired default network function in older persons without dementia.
about
DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD miceArc/Arg3.1 regulates an endosomal pathway essential for activity-dependent β-amyloid generationAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseInhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.The clinical use of structural MRI in Alzheimer diseaseAmyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networksLevetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.Posterior cingulum white matter disruption and its associations with verbal memory and stroke risk in mild cognitive impairmentAmyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderlySpecific and disease stage-dependent episodic memory-related brain activation patterns in Alzheimer’s disease: a coordinate-based meta-analysisTau: The Center of a Signaling Nexus in Alzheimer's DiseaseSuspected non-Alzheimer disease pathophysiology--concept and controversyPotentials and limits to enhance cognitive functions in healthy and pathological aging by tDCSThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsPotential of functional MRI as a biomarker in early Alzheimer's diseaseTesting the right target and right drug at the right stageExplaining the encoding/retrieval flip: memory-related deactivations and activations in the posteromedial cortexBrain imaging in Alzheimer diseaseAt the interface of sensory and motor dysfunctions and Alzheimer's disease.Alternative neural circuitry that might be impaired in the development of Alzheimer diseaseAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseUshering in the study and treatment of preclinical Alzheimer diseaseExisting Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation18F-florbetaben Aβ imaging in mild cognitive impairmentNeuroimaging biomarkers of neurodegenerative diseases and dementiaDo Microglia Default on Network Maintenance in Alzheimer's Disease?Alzheimer's disease: Unique markers for diagnosis & new treatment modalitiesAnalyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesBeta-amyloid deposition and the aging brainValidation of the Face Name Associative Memory Exam in cognitively normal older individualsDifferences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairmentNicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraPathogenic PS1 phosphorylation at Ser367Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeTracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersPET amyloid-beta imaging in preclinical Alzheimer's diseaseCortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease.Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.
P2860
Q21135531-43F8EA04-F131-499A-B8EC-1146C27AEBEFQ24294891-8E22992E-B786-425B-B1F7-8D212917B67DQ24594531-78C8E9DD-4161-4D1F-A168-AA96B4FDE0E1Q24595802-C75A5CF5-C896-4508-A470-AE34ECD58316Q24603560-C053A6C7-0F04-4B2B-86B0-9C7EF42E8729Q24609648-60BF0EDA-6AA1-4575-8CEC-A68E617AB9B1Q24622558-23B139BD-89CE-482D-93F5-050280E906B5Q24624879-3EB25EFC-DE0C-49DE-9F92-9C40C49DDE2FQ24630245-6779556D-FBDE-42A8-A710-E30441D28332Q24634788-BC75776B-967C-4C32-B371-8564B58A3B3DQ24758018-C130A3FD-DF93-4052-A198-E9A9A2B718B5Q26768223-BA9B5276-AA6A-472E-A341-6D5A7DD71B78Q26771270-2C58B12E-15AF-4365-8918-88E296336C97Q26781642-DEB80DDD-70C1-44CE-BAD5-4BFA8FB9C0D3Q26830467-A76CA774-1128-4BA8-9D72-424CF8130114Q26864734-158EE263-169C-423C-BCD5-2AA796804861Q26864854-D7C4F2C8-0B6E-4A14-8137-CC94D189D0DEQ26866075-760A3C9E-0571-4B9F-8AF4-92D8CFF86343Q26996299-B229CE7A-3A36-40BC-9060-35A02A07C01BQ27000410-2C08A40B-AE5A-46C6-8201-812F1FF01F3EQ27001223-ACFF65B9-7B18-4680-B159-AB396D9343F6Q27009411-48F5F228-D214-4C8D-AED7-C261E692636FQ27014791-6768C99C-DADE-4F9A-972E-145B119756DEQ27303745-F8CA0187-6A24-4234-B06F-8EDFC7887572Q27499311-4687B75B-D95A-4B40-A050-974DA2BA9B7BQ27691820-498EE880-FA3D-4A69-B435-17B83E1ED580Q28066112-BD7EBEC6-906B-42FC-A034-A1F51D1988AFQ28085139-A913BFA7-1A3C-4936-B9B8-27F0BBCDF431Q28087158-1F846C25-20BF-4821-AF91-55BEE4A46BE9Q28264556-28E000CA-D897-4B1B-AD73-5F237F95DC2FQ28386196-B9A98675-6D62-4B41-98F2-D525784FD55AQ28649713-85B816D1-B099-4868-BB79-5AB57C301C02Q28730781-62C00532-737D-4D7F-AD39-B7AFA3B77C16Q28817892-A00FB697-938D-4AF6-96FA-4C2353B028CAQ29614407-3CD57BAA-9280-4E98-8935-8A41B2F64B8CQ29620245-8E0ABA72-38A1-4641-AA6D-6A3053E3C78DQ30040695-B6BC0991-D00A-40BA-9AE0-0461A790EC7DQ30361851-E2FDE9F9-37D8-4CD8-BB0E-0CAB86D7F759Q30426091-174756FD-7A45-4272-8CF5-8DF40DB67738Q30436083-5885E0A4-6831-4EFC-A5E2-EF548416C9A1
P2860
Amyloid deposition is associated with impaired default network function in older persons without dementia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid deposition is associat ...... lder persons without dementia.
@en
Amyloid deposition is associat ...... lder persons without dementia.
@nl
type
label
Amyloid deposition is associat ...... lder persons without dementia.
@en
Amyloid deposition is associat ...... lder persons without dementia.
@nl
prefLabel
Amyloid deposition is associat ...... lder persons without dementia.
@en
Amyloid deposition is associat ...... lder persons without dementia.
@nl
P2093
P2860
P1433
P1476
Amyloid deposition is associat ...... lder persons without dementia.
@en
P2093
Dennis J Selkoe
Dorene M Rentz
Gad Marshall
J Alex Becker
Jacqueline O'Brien
Keith A Johnson
Kelly O'Keefe
Maija Pihlajamaki
Peter S Laviolette
Reisa A Sperling
P2860
P304
P356
10.1016/J.NEURON.2009.07.003
P407
P577
2009-07-01T00:00:00Z